Skip to content

Reader Study of DeltaView™ Chest Radiograph Software

Reader Study to Demonstrate That Use of DeltaView™ is Superior to the Use Standard Prior and Current Antero/Posterior (AP/PA) X-ray Image Pair

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01261507
Enrollment
15
Registered
2010-12-16
Start date
2010-11-30
Completion date
2012-12-31
Last updated
2015-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasm

Keywords

lung neoplasm nodule image processing computer-assisted

Brief summary

A new software product takes two chest radiographs, aligns them, and then subtracts one image from the other. The resulting image represents an image showing any differences between them. The study is to determine whether radiologists using this new software perform better with it than when they do not use it.

Interventions

None listed

Sponsors

Riverain Medical Group, Miamisburg, OH
CollaboratorUNKNOWN
BioStat Solutions, Inc., Mt. Airy, MD
CollaboratorINDUSTRY
Georgetown University
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
35 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

For Radiologists: American Board of Radiology Certification and live within the Baltimore, MD-Washington, DC Metropolitan areas For chest radiographs, evidence of the presence or absence of lung nodule confirmed by expert panel; adequate image quality \-

Exclusion criteria

Radiologists who assisted by providing cases for review For chest radiographs: poor image quality

Design outcomes

Primary

MeasureTime frameDescription
Localized Receiver Operating Characteristic (LROC) Comparison1 dayThe area under the LROC curve will be compared for the chest radiograph interpretations done without the new software and those done with the new software. Improvement will be demonstrated if the improvement with the new software is statistically significant at the p=\<0.05. There were 422 cases in the total study. 20 of these were inserted as noise cases, not to be analyzed. Thus there were 402 cases to be analyzed. There were 120 cases with nodules and 282 without a nodule. LROC is a method for measuring the success or failure of a method where there is a tradeoff between the detection of lung nodules that are there (true positives) and the detection that the radiologist considers to be a nodule where no nodule is present (false positive). It yields a single number that done not have a unit of measurement.

Secondary

MeasureTime frameDescription
Sensitivity and Specificity1 daySensitivity and specificity will be measured. If the radiologists using the new software have higher sensitivity, statistically significant at the p=\< 0.05, the use of the new software will be considered to have resulted in improvement. A decrease in specificity is expected.
False Positive Decisions of Radiologists1 dayThis is a comparison of the radiologists working without and with the software. The false positive rate is the percentage of cases in which the radiologists identified a lesions/location suspected of being cancer at a location where cancer was not present. . A false positive represents a location selected on a chest image without cancer and, also, a mark on a chest image where cancer was present, but a different location, one without cancer, was marked.The radiologists could mark up to five locations on an image and had to provide a confidence rating for each. This analysis is of the single mark with the highest confidence level.

Countries

United States

Participant flow

Recruitment details

Recruited by email 15 radiologists practicing in the DC Metro area. Used prior subjects and those referred by prior research subjects.

Pre-assignment details

discussion of project was done with each participant. Any questions were answered and signed consent was obtained. There were no dropouts of those recruited.

Participants by arm

ArmCount
Radiologists
Board Certified Radiologists working in the Washington, DC, Baltimore region
15
Total15

Baseline characteristics

CharacteristicRadiologists
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
15 Participants
Region of Enrollment
United States
15 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 15
serious
Total, serious adverse events
0 / 15

Outcome results

Primary

Localized Receiver Operating Characteristic (LROC) Comparison

The area under the LROC curve will be compared for the chest radiograph interpretations done without the new software and those done with the new software. Improvement will be demonstrated if the improvement with the new software is statistically significant at the p=\<0.05. There were 422 cases in the total study. 20 of these were inserted as noise cases, not to be analyzed. Thus there were 402 cases to be analyzed. There were 120 cases with nodules and 282 without a nodule. LROC is a method for measuring the success or failure of a method where there is a tradeoff between the detection of lung nodules that are there (true positives) and the detection that the radiologist considers to be a nodule where no nodule is present (false positive). It yields a single number that done not have a unit of measurement.

Time frame: 1 day

Population: All participants were included for calculation of A-LROC and Sensitivity-Specificity. All radiographs were interpreted both without and with software assistance

ArmMeasureValue (MEAN)Dispersion
Board Certified Radiologists Working Without SoftwareLocalized Receiver Operating Characteristic (LROC) Comparison0.477 unitlessStandard Error 0.037
Radiologists Working With SoftwareLocalized Receiver Operating Characteristic (LROC) Comparison0.536 unitlessStandard Error 0.037
Comparison: Measure is the difference between the radiologists working without the software less the value for the radiologists working with the software. Thus a negative value would indicate that the the radiologists showed better results when using the software.p-value: <0.0595% CI: [-0.086, -0.031]mixed model:Dorfman, Berbaum, Metz
Secondary

False Positive Decisions of Radiologists

This is a comparison of the radiologists working without and with the software. The false positive rate is the percentage of cases in which the radiologists identified a lesions/location suspected of being cancer at a location where cancer was not present. . A false positive represents a location selected on a chest image without cancer and, also, a mark on a chest image where cancer was present, but a different location, one without cancer, was marked.The radiologists could mark up to five locations on an image and had to provide a confidence rating for each. This analysis is of the single mark with the highest confidence level.

Time frame: 1 day

ArmMeasureValue (MEAN)Dispersion
Board Certified Radiologists Working Without SoftwareFalse Positive Decisions of Radiologists9.7 percentage of marks not on cancersStandard Error 1.9
Radiologists Working With SoftwareFalse Positive Decisions of Radiologists11.2 percentage of marks not on cancersStandard Error 1.9
Secondary

Sensitivity and Specificity

Sensitivity and specificity will be measured. If the radiologists using the new software have higher sensitivity, statistically significant at the p=\< 0.05, the use of the new software will be considered to have resulted in improvement. A decrease in specificity is expected.

Time frame: 1 day

ArmMeasureGroupValue (MEAN)Dispersion
Board Certified Radiologists Working Without SoftwareSensitivity and SpecificitySensitivity: correct detection of cancer43.8 Percentage of casesStandard Error 0.36
Board Certified Radiologists Working Without SoftwareSensitivity and SpecificitySpecificity: cancer free cases correctly identifie94.1 Percentage of casesStandard Error 0.12
Radiologists Working With SoftwareSensitivity and SpecificitySensitivity: correct detection of cancer50.1 Percentage of casesStandard Error 0.36
Radiologists Working With SoftwareSensitivity and SpecificitySpecificity: cancer free cases correctly identifie92.6 Percentage of casesStandard Error 0.12

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026